Zynex Inc (Zynex) is a medical technology company that designs, manufactures and markets electrotherapy medical devices used in pain management and rehabilitation. The company’s products include NexWave, a dual-channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation devices; NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. It also offers Comfortrac for cervical traction; JetStream for hot and cold therapy; and Aspen LSO Back Braces for lumbar support. Zynex offers products for home use, cardiac monitoring and EMG and EEG diagnostic purposes in the neurology clinical market. The company markets its products through a network of medical distributors. Zynex is headquartered in Englewood, Colorado, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Zynex Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Zynex Inc Company Overview
Zynex Inc Company Snapshot
Zynex Inc Pipeline Products and Ongoing Clinical Trials Overview
Zynex Inc – Pipeline Analysis Overview
Business Description
Zynex Inc - Key Facts
Zynex Inc - Major Products and Services
Zynex Inc Pipeline Products by Development Stage
Zynex Inc Pipeline Products Overview
HemeOx
HemeOx Product Overview
NiCO
NiCO Product Overview
NiCO CO-Oximeter
NiCO CO-Oximeter Product Overview
Non-Invasive Sepsis Monitor
Non-Invasive Sepsis Monitor Product Overview
Zynex Inc - Key Competitors
Zynex Inc - Key Employees
Zynex Inc - Key Employee Biographies
Zynex Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Zynex Inc, Recent Developments
Sep 06, 2024: Zynex Receives 510(k) Clearance For TENSWave
Sep 04, 2024: FDA clears Zynex’s TensWave device for pain management
Feb 22, 2024: Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call
Feb 08, 2024: Zynex Medical Receives 510(K) Clearance For M-Wave
Feb 07, 2024: Zynex’s new NMES device secures FDA clearance
Nov 14, 2023: Zynex seeks FDA approval for M-Wave NMES device
Aug 10, 2023: Zynex Announces 1 Millionth Patient Milestone
Aug 09, 2023: Zynex Announces New Therapy Products
Jul 05, 2023: Zynex Medical Receives 510(k) Clearance for Zynex Monitoring System Model CM-1600
Jun 20, 2023: Zynex Receives FDA Clearance of CM-1600 Monitor for Improved Blood and Fluid Management
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Zynex Inc Pipeline Products and Ongoing Clinical Trials Overview
Zynex Inc Pipeline Products by Equipment Type
Zynex Inc Pipeline Products by Indication
Zynex Inc, Key Facts
Zynex Inc, Major Products and Services
Zynex Inc Number of Pipeline Products by Development Stage
Zynex Inc Pipeline Products Summary by Development Stage